Skip to main content

Peer Review reports

From: Cost-effectiveness of the combination of immunotherapy and chemotherapy for extensive-stage small-cell lung cancer: a systematic review

Original Submission
11 Sep 2022 Submitted Original manuscript
13 Oct 2022 Author responded Author comments - Tao Wang
Resubmission - Version 2
13 Oct 2022 Submitted Manuscript version 2
28 Jan 2023 Reviewed Reviewer Report
8 Apr 2023 Reviewed Reviewer Report
9 May 2023 Author responded Author comments - Tao Wang
Resubmission - Version 3
9 May 2023 Submitted Manuscript version 3
26 May 2023 Reviewed Reviewer Report
26 May 2023 Reviewed Reviewer Report
4 Jun 2023 Author responded Author comments - Tao Wang
Resubmission - Version 4
4 Jun 2023 Submitted Manuscript version 4
13 Jun 2023 Author responded Author comments - Tao Wang
Resubmission - Version 5
13 Jun 2023 Submitted Manuscript version 5
Publishing
20 Jun 2023 Editorially accepted
26 Jun 2023 Article published 10.1186/s12913-023-09727-7

You can find further information about peer review here.

Back to article page